264 related articles for article (PubMed ID: 36397154)
21. Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients.
Gaj P; Habior A; Mikula M; Ostrowski J
BMC Med Genet; 2008 Aug; 9():81. PubMed ID: 18715515
[TBL] [Abstract][Full Text] [Related]
22. [Cholestatic liver diseases].
Grimm D; Thimme R
Ther Umsch; 2011 Apr; 68(4):195-9. PubMed ID: 21452140
[TBL] [Abstract][Full Text] [Related]
23. Prospective evaluation of PBC-specific health-related quality of life questionnaires in patients with primary sclerosing cholangitis.
Raszeja-Wyszomirska J; Wunsch E; Krawczyk M; Rigopoulou EI; Bogdanos D; Milkiewicz P
Liver Int; 2015 Jun; 35(6):1764-71. PubMed ID: 25388280
[TBL] [Abstract][Full Text] [Related]
24. PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC.
Kruk B; Liebe R; Milkiewicz M; Wunsch E; Raszeja-Wyszomirska J; Lammert F; Milkiewicz P; Krawczyk M
PLoS One; 2018; 13(8):e0202942. PubMed ID: 30161167
[TBL] [Abstract][Full Text] [Related]
25. Manganese and copper levels in patients with primary biliary cirrhosis and primary sclerosing cholangitis.
Dastych M; Husová L; Aiglová K; Fejfar T; Dastych M
Scand J Clin Lab Invest; 2021 Apr; 81(2):116-120. PubMed ID: 33428478
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease.
Duengelhoef P; Hartl J; Rüther D; Steinmann S; Brehm TT; Weltzsch JP; Glaser F; Schaub GM; Sterneck M; Sebode M; Weiler-Normann C; Addo MM; Lütgehetmann M; Haag F; Schramm C; Schulze Zur Wiesch J; Lohse AW
United European Gastroenterol J; 2022 Apr; 10(3):319-329. PubMed ID: 35289983
[TBL] [Abstract][Full Text] [Related]
27. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.
Franco J; Saeian K
Curr Gastroenterol Rep; 1999 Apr; 1(2):95-101. PubMed ID: 10980934
[TBL] [Abstract][Full Text] [Related]
28. Comparative histologic features among liver biopsies with biliary-pattern injury and confirmed clinical diagnoses.
Yu S; Vidal B; Peric M; Rosenbaum MW; Cates JMM; Gonzalez RS
Hum Pathol; 2024 Apr; 146():8-14. PubMed ID: 38479481
[TBL] [Abstract][Full Text] [Related]
29. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Stättermayer AF; Halilbasic E; Wrba F; Ferenci P; Trauner M
J Hepatol; 2020 Sep; 73(3):651-663. PubMed ID: 32376413
[TBL] [Abstract][Full Text] [Related]
30. Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis.
Fejfar T; Vaňásek T; Hůlek P
Vnitr Lek; 2020; 66(5):287-300. PubMed ID: 32942866
[TBL] [Abstract][Full Text] [Related]
31. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
[TBL] [Abstract][Full Text] [Related]
32. Variant and Specific Forms of Autoimmune Cholestatic Liver Diseases.
Dalekos GN; Gatselis NK
Arch Immunol Ther Exp (Warsz); 2019 Aug; 67(4):197-211. PubMed ID: 31165900
[TBL] [Abstract][Full Text] [Related]
33. Overlap Syndromes.
Chazouillères O
Dig Dis; 2015; 33 Suppl 2():181-7. PubMed ID: 26641819
[TBL] [Abstract][Full Text] [Related]
34. Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.
Stallhofer J; Denk GU; Glas J; Laubender RP; Göke B; Rust C; Brand S; Pusl T
Digestion; 2011; 84(1):29-35. PubMed ID: 21304239
[TBL] [Abstract][Full Text] [Related]
35. Cholestatic Liver Injury: Care of Patients With Primary Biliary Cholangitis or Primary Sclerosing Cholangitis.
Larson L; James M; Gossard A
AACN Adv Crit Care; 2016 Oct; 27(4):441-452. PubMed ID: 27959300
[TBL] [Abstract][Full Text] [Related]
36. Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.
de Vries E; Bolier R; Goet J; Parés A; Verbeek J; de Vree M; Drenth J; van Erpecum K; van Nieuwkerk K; van der Heide F; Mostafavi N; Helder J; Ponsioen C; Oude Elferink R; van Buuren H; Beuers U;
Gastroenterology; 2021 Feb; 160(3):734-743.e6. PubMed ID: 33031833
[TBL] [Abstract][Full Text] [Related]
37. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
Mattner J
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
[TBL] [Abstract][Full Text] [Related]
38. Overlap syndromes.
Beuers U; Rust C
Semin Liver Dis; 2005 Aug; 25(3):311-20. PubMed ID: 16143946
[TBL] [Abstract][Full Text] [Related]
39. Chronic cholestatic diseases.
Poupon R; Chazouillères O; Poupon RE
J Hepatol; 2000; 32(1 Suppl):129-40. PubMed ID: 10728800
[TBL] [Abstract][Full Text] [Related]
40. Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis.
Lammert C; Juran BD; Schlicht E; Xie X; Atkinson EJ; de Andrade M; Lazaridis KN
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1562-8. PubMed ID: 24440215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]